Academic Journal
Portal hypertension syndrome in children with autosomal recessive polycystic kidney disease with liver cysts and hepatic fibrosis ; Синдром портальной гипертензии у детей с аутосомно-рецессивной поликистозной болезнью почек, кистозом и фиброзом печени
| العنوان: | Portal hypertension syndrome in children with autosomal recessive polycystic kidney disease with liver cysts and hepatic fibrosis ; Синдром портальной гипертензии у детей с аутосомно-рецессивной поликистозной болезнью почек, кистозом и фиброзом печени |
|---|---|
| المؤلفون: | E. F. Andreeva, I. V. Dyug, L. G. Goryacheva, N. D. Savenkova, Э. Ф. Андреева, И. В. Дюг, Л. Г. Горячева, Н. Д. Савенкова |
| المصدر: | Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 68, № 3 (2023); 61-67 ; Российский вестник перинатологии и педиатрии; Том 68, № 3 (2023); 61-67 ; 2500-2228 ; 1027-4065 |
| بيانات النشر: | Ltd. “The National Academy of Pediatric Science and Innovation” |
| سنة النشر: | 2023 |
| المجموعة: | Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) / Российский вестник перинатологии и педиатрии |
| مصطلحات موضوعية: | синдром портальной гипертензии, hepatic fibrosis, liver cystosis, portal hypertension syndrome, фиброз печени, кистоз печени |
| الوصف: | Hepatic fibrosis, liver cysts, and portal hypertension are extrarenal manifestations that determine the prognosis of autosomal recessive polycystic kidney disease in children.Purpose. To assess the features of the manifestation and course of liver cystic disease and fibrosis, the development of portal hypertension in the follow-up medical history of children with autosomal recessive polycystic kidney disease.Material and methods. We studied 27 children with autosomal recessive polycystic kidney disease, with two children with a fatal outcome in the neonatal period excluded. 25 children 1–17 years old with autosomal recessive polycystic kidney disease were divided into 2 groups depending on the presence of portal hypertension syndrome. In the long-term follow-up 10 (40%) of 25 children with autosomal recessive polycystic kidney disease had no signs of portal hypertension (group 1), 15 (60%) children had portal hypertension syndrome (group 2). The long-term follow-up, clinical, genealogical, laboratory and instrumental (US, MRI/CT of kidney and abdominal cavity, liver elastography) research methods were used in the study. The diagnosis was confirmed by autopsy for 3 children.Results. There were no cases of changes in the liver and bile ducts characteristic of autosomal recessive polycystic kidney disease by prenatal ultrasound examination. From 27 children with autosomal recessive polycystic kidney disease, in 10 (37%) were diagnosed the liver fibrosis in the long-term follow-up, 22 (81%) had cystic enlargement of intrahepatic veins, of which 15 (68%) had polycystic liver disease, 3 (14%) had Caroli disease. All children with autosomal recessive polycystic kidney disease and portal hypertension syndrome had varicose veins of the esophagus and stomach according to esophagoduodenoscopy, 53% with indications for ligation of phlebectasia, 47% were diagnosed with thrombocytopenia, 67% with anemia, 100% with splenomegaly, 13% with esophageal-gastric bleeding.Conclusion. The differences in the initial manifestations of ... |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | Russian |
| Relation: | https://www.ped-perinatology.ru/jour/article/view/1827/1378; An online catalog of human genes and genetic disorders. https://omim.org / Ссылка активна на 04.03.2023; Burgmaier K., Brinker L., Erger F., Beck B.B., Benz M.R., Bergmann C. et al. Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants. Kid Int 2021; 100: 650–659. DOI:10.1016/j.kint.2021.04.019; Liebau M.C., Guay-Woodford L.M. Autosomal recessive polycystic kidney disease. In Pediatric Nephrology 8-th ed. Editors F. Emma, S.L. Goldstein, A. Bagga, C.M. Bates, R. Shroff. Springer, 2022: 1197–1212. DOI:10.1007/978–3–030–52719–8_117; Lasagni A., Cadamuro M., Morana G., Fabris L., Strazzabosco M. Fibrocystic liver disease: novel concepts and translational perspectives. Transl Gastroent Hepatol 2021; 6: 26. DOI:10.21037/tgh-2020–04; Sharbidre K., Zahid M., Venkatesh S.K., Bhati C., Lalwani N. Imaging of fibropolycystic liver disease. Abdom Radiol (NY) 2022; 47(7): 2356–2370. DOI:10.1007/s00261–022–03565–7; Hasbaoui B.E., Rifai Z., Saghir S., Ayad A., Lamalmi N., Abilkassem R., Agadr A. Congenital hepatic fibrosis: case report and review of literature. Pan Afr Med J 2021; 38: 188. DOI:10.11604/pamj.2021.38.188.27941; Olaizola P., Rodrigues P.M., Caballero-Camino F.J., Izquierdo- Sanchez L., Aspichueta P., Bujanda L. et al. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease. Nat Rev Gastroent Hepatol 2022; 19(9): 585–604. DOI:10.1038/s41575–022–00617–7; Wicher D., Grenda R., Teisseyre M., Szymczak M., Halat-Wolska P., Jurkiewicz D. et al. Occurrence of portal hypertension and its clinical course in patients with molecularly confirmed autosomal recessive polycystic kidney disease (ARPKD). Front Pediatr 2020; 8: 591379. DOI:10.3389/fped.2020.591379; Fon Gabršček A., Meglič A., Novljan G., Kersnik Levart T., Rus R. Clinical characteristics of Slovenian pediatric patients with autosomal recessive polycystic kidney disease. Clin nephrol 2021; 96(1): 56–61. DOI:10.5414/CNP96S10; Shejul Dh.D., Shaikh A.A., Anbhule S.J. Overview of polycystic liver and kidney disease. IJNRD 2022; 7(11): b321–b328. www.ijnrd.org/papers/IJNRD2211134.pdf / Ссылка активна на 04.03.2023; Hartung E.A., Wen J., Poznick L., Furth S.L., Darge K. Ultrasound elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease. J Pediatr 2019; 209: 107–115. DOI:10.1016/j.jpeds.2019.01.055; Hartung E.A., Calle‑Toro J.S., Lopera C.M., Wen J., Carson R.H., Dutt M. et al. Magnetic resonance elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease. Abdom Radiol (NY) 2021; 46(2): 570–580. DOI:10.1007/s00261–020–02694–1; Ефремова Н.А., Горячева Л.Г., Карабак И.А. Cовременные методы диагностики фиброза печени у детей. Педиатр 2020;11(4):43–54.; Acevedo E., Laínez S.S., Cáceres Cano P.A., Vivar D. Caroli’s syndrome: an early presentation. Cureus 2020; 12(10): e11029. DOI:10.7759/cureus.11029; Dorval G., Boyer O., Couderc A., Delbet J-D., Heidet L., Debray D. et al. Long-term kidney and liver outcome in 50 children with autosomal recessive polycystic kidney disease. Pediatr Nephrol 2021; 36(5): 1165–1173. DOI:10.1007/s00467–020–04808–9; Ghannam J.S., Cline M.R., Hage A.N., Chick J.F.B., Srinivasa R.N., Dasika N.L. et al. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience. Pediatr Radiol 2019; 49(1): 128–135. DOI:10.1007/s00247–018–4267–9; Андреева Э.Ф., Савенкова Н.Д. Течение аутосомно-доминантного и аутосомно-рецессивного поликистоза почек (АДПП и АРПБП), выявленных в пренатальном, неонатальном и грудном периодах у детей. Нефрология 2019; 23(5): 77–87.; Андреева Э.Ф., Савенкова Н.Д. Ренальное маловодие и Поттер-последовательность при кистозных заболеваниях почек. Российский вестник перинатологии и педиатрии 2021;66(1):47–51.; Савенкова Н.Д., Левиашвили Ж.Г., Андреева Э.Ф., Семенова О.А., Папаян К.А. Наследственные болезни почек у детей. Руководство для врачей под ред. Н.Д. Савенковой. СПб.: Левша. Санкт-Петербург, 2020; 440 с.; Андреева Э.Ф., Савенкова Н.Д. Кистозные болезни почек у детей (обзор литературы). Нефрология 2012;16(3/2):34–47.; Ajiri R., Burgmaier K., Akinci N., Broekaert I., Büscher A., Dursun I. et al. Phenotypic variability in siblings with autosomal recessive polycystic kidney disease. Kidney Int Rep 2022; 7(7): 1643–1652. DOI:10.1016/j.ekir.2022.04.095; Ghosh A., Serai S.D., Venkatakrishna Sh.S.B., Dutt M., Hartung E.A. Twodimensional (2D) morphologic measurements can quantify the severity of liver disease in children with autosomal recessive polycystic kidney disease (ARPKD). Abdom Radiol 2021; 46(10): 4709–4719. DOI:10.1007/s00261–021–03189–3; Selen T., Akoglu H., Agbaht K. Relationship between liver function tests and cardiovascular risk factors in stage 3–5 pre-dialysis chronic kidney disease. Indian J Med Res 2022; 155(3): 397–402. DOI:10.4103/ijmr.IJMR_1777_19; Shibata M., Sato K.K., Uehara S., Koh H., Oue K., Kambe H. et al. Serum gamma-glutamyltransferase, daily alcohol consumption and the risk of chronic kidney disease: the Kansai healthcare study. J Epidemiol 2020; 30(4): 163–169. DOI:10.2188/jea.JE20180240; Ranawaka R., Dayasiri K., Gamage M. Combined liver and kidney transplantation in children and long-term outcome. World J Transplant 2020; 10(10): 283–290. DOI:10.5500/wjt.v10.i10.283; Salehi A., Dehghani S.M., Vardenjani H.M., Darban B., Ghandour F. Comparison of lymphocyte-to-monocyte ratio with Child-Pugh and PELD/MELD scores to predict the outcome of children with cirrhosis. Clin Exp Hepatol 2021; 7(4): 351–357. DOI:10.5114/ceh.2021.111419; Wu W.K., Ziogas I.A., Izzy M., Pai A.K., Hafberg E.T., Matsuoka L.K., Alexopoulos S.P. Liver transplantation for congenital hepatic fibrosis. Transpl Int 2021; 34(7): 1281–1292. DOI:10.1111/tri.13884; https://www.ped-perinatology.ru/jour/article/view/1827 |
| DOI: | 10.21508/1027-4065-2023-68-3-61-67 |
| الاتاحة: | https://www.ped-perinatology.ru/jour/article/view/1827 https://doi.org/10.21508/1027-4065-2023-68-3-61-67 |
| Rights: | Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |
| رقم الانضمام: | edsbas.9DA8E1F |
| قاعدة البيانات: | BASE |
| DOI: | 10.21508/1027-4065-2023-68-3-61-67 |
|---|